ReviewEuropean journal of clinical nutrition2021
Green tea and cancer and cardiometabolic diseases: a review of the current epidemiological evidence.
Review in European journal of clinical nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.
- Pooled it
- Non-Genetic Risk Factors for Parkinson's Disease: An Overview of 46 Systematic Reviews.Journal of Parkinson's disease · 2021Pooled it
- Effect of fluid replacement with green tea on body fluid balance and renal responses under mild thermal hypohydration: a randomized crossover study.European journal of nutrition · 2023Trial
- Association of Green Tea Consumption and the Risk of Liver Cancer Incidence among Japanese Adults.Asian Pacific journal of cancer prevention : APJCP · 2026Article
- Functional Food Potential of White Tea from East Black Sea Region: Targeting GREM1 Expression and Metabolic Dysregulation in Obesity.International journal of molecular sciences · 2026Article
- The relationship between green tea consumption and happiness.Scientific reports · 2025Article
- Association of herbal tea consumption with cardiovascular diseases in the general population: evidence from the MESA cohort.Nutrition journal · 2025Article
- The Association Between Tea Consumption Timing and Kidney Function: Insights From a National Survey.Food science & nutrition · 2025Article
- Hot beverage intake and oesophageal cancer in the UK Biobank: prospective cohort study.British journal of cancer · 2025Observational
- Investigating the synergistic antioxidant behavior of catechin and copper ion in tea: The mechanism of coordination-activation effect.Food chemistry: X · 2025Article
- Formulation and Evaluation of the Antioxidant Activity of an Emulsion Containing a Commercial Green Tea Extract.Molecules (Basel, Switzerland) · 2025Article
- Tea consumption may improve psychological resilience among older adults with chronic diseases: a prospective cohort study.Frontiers in psychiatry · 2025Article
- Navigating the redox landscape: reactive oxygen species in regulation of cell cycle.Redox report : communications in free radical research · 2024Review
- The possible role furin and furin inhibitors in endometrial adenocarcinoma: A narrative review.Cancer reports (Hoboken, N.J.) · 2024Review
- Understanding and exploring the diversity of soil microorganisms in tea (Frontiers in microbiology · 2024Review
- Application of a Two-Dimensional Mapping-Based Visualization Technique: Nutrient-Value-Based Food Grouping.Nutrients · 2023Article
- Impact of Green Tea Consumption on the Prevalence of Cardiovascular Outcomes: A Systematic Review.Cureus · 2023Review
- Association of unsweetened and sweetened tea consumption with the risk of new-onset chronic kidney disease: Findings from UK Biobank and Coronary Artery Risk Development in Young Adults (CARDIA) study.Journal of global health · 2023Article
- Review
- The healthy beverage index is not associated with insulin resistance, prediabetes and type 2 diabetes risk in the Rotterdam Study.European journal of nutrition · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Green tea is commonly consumed in China, Japan, and Korea and certain parts of North Africa and is gaining popularity in other parts of the world. The aim of this review was to objectively evaluate the existing evidence related to green tea consumption and various health outcomes, especially cancer, cardiovascular disease and diabetes. This review captured evidence from meta-analyses as well as expert reports and recent individual studies. For certain individual cancer sites: endometrial, lung, oral and ovarian cancer, and non-Hodgkins lymphoma the majority of meta-analyses observed an inverse association with green tea. Mixed findings were observed for breast, esophageal, gastric, liver and a mostly null association for colorectal, pancreatic, and prostate cancer. No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea. The literature overall supports an inverse association between green tea and cardiovascular disease-related health outcomes. The evidence for diabetes-related health outcomes is less convincing, while the included meta-analyses generally suggested an inverse association between green tea and BMI-related and blood pressure outcomes. Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes, dental health, injuries and respiratory disease. This review concludes that green tea consumption overall may be considered beneficial for human health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.